Written by: John LinDahl There are many myths about options being risky. While risk is inherent in any investment, options, when used correctly, can mitigate risk, and increase profit. Have you ever bought a stock because you thought it was going to go up, but instead it went up a little, down a little, [...]
Palantir Technologies (PLTR) has been on a torrent charge through 2024 thus far, up more than 133% - and up 156% since this time last year. While the industry has a whole has boomed, this particular stock has outpaced its peers by nearly 28%. The question is, should you still buy PLTR today, or [...]
How do you build a high performing Trading Plan that delivers year in and year out? VectorVest provides you with the best performing Trading Systems each day and designed and tested by VectorVest. This can be found per our Trading system viewer. A snapshot as of 3 October 2024 is per below, showcasing our high [...]
It’s like clockwork. Anytime there’s tension in the Middle East it poses a threat to the world’s oil supply, and prices surge accordingly. That’s what we’re seeing this morning for energy stocks like Chevron (CVX) and ExxonMobil (XOM). These stocks are up nearly 6% and 7% respectively in the past week, and they’re up [...]
Nike Inc. (NKE) is down roughly 6% Wednesday morning after the company’s earnings day Tuesday left much to be desired in the eyes of investors. The company is still struggling to regain its footing, and after withdrawing its full-year guidance, it’s clear that the road ahead will continue to be rocky. Here’s how the [...]
Shares of Stellantis NV (STLA) are down 11% in the past week as the Netherlands-based automaker was forced to lower its full-year forecast as costs are climbing while production is falling. The company was originally expecting to deliver a double-digit profit percentage for the fiscal year, but now, the profit guidance has been brought [...]
Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug. The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious [...]
Monday: The Major Indices started the week in positive territory with investors keeping an eye on the upcoming Personal Consumption Expenditures report. The Dow rose 0.2%, the S&P 500 gained 0.3%, and the Nasdaq added 0.1%. Tuesday: China's new stimulus plan helped boost sentiment despite lower-than-expected housing data, leading to another day of gains. [...]
Written by: Angela Akers In last week’s “Special Presentation,” Mr. Steve Chappell discussed and demonstrated the efficacy and effectiveness of the VectorVest RealTime Derby. The Derby analyzes, sorts, ranks and graphs the second-by-second performance of 169 portfolios. It tracks each portfolio’s performance from the current day’s opening bell and displays the results from the [...]
Shares of Accenture (ACN) are up just under 6% in the past week amidst hype for the company’s AI-powered performance in the fourth quarter. The business management consultant posted adjusted earnings per share of $2.79, which matched the analyst consensus. Revenue of $16.41 billion was a 2.6% improvement year over year and ahead of [...]
